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Designer drugs are getting popular among teenagers and young adult is a serious problem. 
Synthetic cannabinoids (SCs) are the most rapidly growing group of designer drugs that mimic 
the natural cannabinoid effects. SCs have hundreds of street names (synthetic marijuana, fake 
weed, Spice, K2 etc.) and these products are sold in packages containing saturated various plants 
crumb. Unfortunately, these drugs can be easily overdosed due to their significantly higher 
binding affinities to the CB1 and CB2 cannabinoid receptors than Δ9-tetrahydrocannabinol as 
the main active ingredient of cannabis.  
The consumption of SCs is verified in urine and blood samples with ultra-high performance 
liquid chromatography coupled to tandem mass spectrometer (UHPLC-MS/MS) technique. In 
most cases, it is not enough to detect only the mother compounds for confirmation of SCs 
consumption, due to their rapid metabolism. The most seized SCs by the police in recent months 
were 5F-MDMB-PICA and 4F-MDMB-BICA.  
Our study aimed to quantitatively determine these new SCs and their main metabolites in 
biological samples (urine and blood) by developed targeted UHPLC-MS/MS method. In 
general, the concentration of the metabolites was significantly higher than the mother 
compound. Thus, it is necessary to identify metabolites to prove the fact of consumption. 
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